(GD) General Dynamics - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NYSE (USA) | Market Cap: 92.293m USD | Total Return: 24.5% in 12m
Industry Rotation: -5.0
Avg Turnover: 483M USD
Peers RS (IBD): 41.7
EPS Trend: 76.2%
Qual. Beats: 0
Rev. Trend: 94.2%
Qual. Beats: 5
Warnings
No concerns identified
Tailwinds
No distinct edge detected
General Dynamics operates as a global aerospace and defense company. The company diversifies across four segments: Aerospace, Marine Systems, Combat Systems, and Technologies.
The Aerospace segment focuses on business jet manufacturing and related support services. This sector is characterized by long product lifecycles and high capital investment.
Marine Systems designs and constructs naval vessels, including nuclear submarines, for the U.S. Navy. This segment operates within a highly specialized defense contracting model, often involving multi-year government contracts.
Combat Systems produces land combat vehicles and weapon systems. This area often involves international sales and upgrades to existing defense platforms.
The Technologies segment provides IT solutions, communication systems, and intelligence services to government clients, including cybersecurity and AI development. Government IT spending is a significant driver in this space.
For more detailed financial analysis and performance metrics, consider researching GD on ValueRay.
- Government defense spending dictates Marine Systems and Combat Systems revenue
- Global business jet demand impacts Aerospace segment profitability
- Technologies segment growth tied to government IT modernization contracts
- Supply chain disruptions increase manufacturing costs across all segments
| Net Income: 4.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.20 > 1.0 |
| NWC/Revenue: 14.18% < 20% (prev 13.75%; Δ 0.43% < -1%) |
| CFO/TA 0.09 > 3% & CFO 5.12b > Net Income 4.21b |
| Net Debt (7.46b) to EBITDA (6.10b): 1.22 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (273.9m) vs 12m ago -1.08% < -2% |
| Gross Margin: 15.13% > 18% (prev 0.15%; Δ 1.50k% > 0.5%) |
| Asset Turnover: 92.90% > 50% (prev 85.39%; Δ 7.51% > 0%) |
| Interest Coverage Ratio: 17.25 > 6 (EBITDA TTM 6.10b / Interest Expense TTM 314.0m) |
| A: 0.13 (Total Current Assets 24.25b - Total Current Liabilities 16.80b) / Total Assets 57.25b |
| B: 0.77 (Retained Earnings 44.08b / Total Assets 57.25b) |
| C: 0.10 (EBIT TTM 5.42b / Avg Total Assets 56.56b) |
| D: 1.39 (Book Value of Equity 44.08b / Total Liabilities 31.63b) |
| Altman-Z'' Score: 5.47 = AAA |
| DSRI: 0.87 (Receivables 10.79b/11.22b, Revenue 52.55b/47.72b) |
| GMI: 1.02 (GM 15.13% / 15.43%) |
| AQI: 0.99 (AQ_t 0.45 / AQ_t-1 0.45) |
| SGI: 1.10 (Revenue 52.55b / 47.72b) |
| TATA: -0.02 (NI 4.21b - CFO 5.12b) / TA 57.25b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
Over the past week, the price has changed by -2.73%, over one month by -3.92%, over three months by -7.28% and over the past year by +24.53%.
- StrongBuy: 6
- Buy: 4
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 393.9 | 16.2% |
P/E Forward = 20.9205
P/S = 1.7563
P/B = 3.6021
P/EG = 2.4682
Revenue TTM = 52.55b USD
EBIT TTM = 5.42b USD
EBITDA TTM = 6.10b USD
Long Term Debt = 7.01b USD (from longTermDebt, last quarter)
Short Term Debt = 1.30b USD (from shortTermDebt, last quarter)
Debt = 9.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.46b USD (from netDebt column, last quarter)
Enterprise Value = 99.75b USD (92.29b + Debt 9.79b - CCE 2.33b)
Interest Coverage Ratio = 17.25 (Ebit TTM 5.42b / Interest Expense TTM 314.0m)
EV/FCF = 25.20x (Enterprise Value 99.75b / FCF TTM 3.96b)
FCF Yield = 3.97% (FCF TTM 3.96b / Enterprise Value 99.75b)
FCF Margin = 7.53% (FCF TTM 3.96b / Revenue TTM 52.55b)
Net Margin = 8.01% (Net Income TTM 4.21b / Revenue TTM 52.55b)
Gross Margin = 15.13% ((Revenue TTM 52.55b - Cost of Revenue TTM 44.60b) / Revenue TTM)
Gross Margin QoQ = 14.89% (prev 15.25%)
Tobins Q-Ratio = 1.74 (Enterprise Value 99.75b / Total Assets 57.25b)
Interest Expense / Debt = 0.64% (Interest Expense 63.0m / Debt 9.79b)
Taxrate = 18.30% (256.0m / 1.40b)
NOPAT = 4.43b (EBIT 5.42b * (1 - 18.30%))
Current Ratio = 1.44 (Total Current Assets 24.25b / Total Current Liabilities 16.80b)
Debt / Equity = 0.38 (Debt 9.79b / totalStockholderEquity, last quarter 25.62b)
Debt / EBITDA = 1.22 (Net Debt 7.46b / EBITDA 6.10b)
Debt / FCF = 1.88 (Net Debt 7.46b / FCF TTM 3.96b)
Total Stockholder Equity = 23.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.44% (Net Income 4.21b / Total Assets 57.25b)
RoE = 17.57% (Net Income TTM 4.21b / Total Stockholder Equity 23.97b)
RoCE = 17.49% (EBIT 5.42b / Capital Employed (Equity 23.97b + L.T.Debt 7.01b))
RoIC = 13.60% (NOPAT 4.43b / Invested Capital 32.55b)
WACC = 6.49% (E(92.29b)/V(102.08b) * Re(7.12%) + D(9.79b)/V(102.08b) * Rd(0.64%) * (1-Tc(0.18)))
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.36%
[DCF] Terminal Value 81.91% ; FCFF base≈3.65b ; Y1≈3.02b ; Y5≈2.18b
[DCF] Fair Price = 184.2 (EV 57.35b - Net Debt 7.46b = Equity 49.90b / Shares 270.8m; r=6.49% [WACC]; 5y FCF grow -21.06% → 3.0% )
EPS Correlation: 76.18 | EPS CAGR: 13.31% | SUE: 0.45 | # QB: 0
Revenue Correlation: 94.20 | Revenue CAGR: 12.03% | SUE: 2.46 | # QB: 5
EPS next Quarter (2026-06-30): EPS=3.86 | Chg7d=-0.011 | Chg30d=+0.006 | Revisions Net=-1 | Analysts=15
EPS current Year (2026-12-31): EPS=16.29 | Chg7d=-0.017 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+5.5% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=18.03 | Chg7d=-0.058 | Chg30d=-0.064 | Revisions Net=-1 | Growth EPS=+10.7% | Growth Revenue=+4.5%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = -1.1% (Analyst 2.3% - Implied 3.4%)